抵抗性和复发性无质性贫血的治疗策略 - - 挑战和新兴希望:一篇综述
1Dongguan Key Laboratory of Clinical Medical Test Diagnostic Technology for Oncology, Dongguan Labway Clinical Laboratory Co., Ltd., Dongguan 523429, Guangdong, China.
Current topics in medicinal chemistry
|March 15, 2026
概括
严重无形性贫血 (SAA) 治疗正在推进,有新的选择,如救援免疫抑制疗法 (IST) 和血造干细胞移植 (HSCT). 新的药物和替代捐赠者为耐药SAA患者提供了更好的结果.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 无形性贫血 (AA) 是一种严重的骨髓衰竭疾病.
- 耐药和复发病例带来了重大的治疗挑战.
研究的目的:
- 审查严重无性贫血 (SAA) 治疗的最新进展.
- 强调新的治疗方式及其对患者结果的影响.
主要方法:
- 审查关于SAA治疗的当前文献.
- 拯救性免疫抑制疗法 (IST) 和血造干细胞移植 (HSCT) 疗效和安全性的分析.
- 对血栓形成素受体激活剂 (TPO-RAs) 和替代性供体HSCT的评估.
主要成果:
- IST和HSCT仍然是SAA的基石治疗方法.
- 埃尔特罗姆波巴格 (TPO-RA) 在耐火SAA中表现有前途.
- 替代捐赠者HSCT (带血) 扩大了治疗选择.
- 新兴的免疫调节药物需要进一步调查.
结论:
- 个性化,机制驱动的策略对于管理耐火SAA至关重要.
- 新的药物和替代捐赠来源正在改善患者的护理和治疗结果.
- 持续的研究对于优化SAA治疗方案至关重要.
相关概念视频
Bone Marrow Sampling and Transplants
2.2K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Stem Cell Therapy for Tissue Regeneration
4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Heart Failure VI: Adjunct Therapies
506
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
506
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
639
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
639


